Concentric Analgesics is a biotechnology company that develops non-opioid therapeutics for the management of acute and chronic pain.
Concentric Analgesics is developing a portfolio of novel, non-opioid therapeutics that provide pain relief after a single local administration. It is a biotechnology company focused on developing non-opioid therapeutics for the management of acute and chronic pain.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 26, 2022 | Convertable Note | $20M | — | — | — | Detail |
May 22, 2019 | Series B | $77.10M | 3 | Oracle Investment Management Inc. | — | Detail |
Aug 17, 2016 | Series Unknown | $5.97M | — | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Oracle Investment Management Inc. | Yes | Series B |
Cowen Healthcare Investments | — | Series B |
Venrock | — | Series B |